Cancer Treatment Market Research Reports & Industry Analysis
Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.
With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.
Cancer Treatment Industry Research & Market Reports
-
Advanced Breast Cancer in Premenopausal Women - Pipeline Insight, 2024
... development scenario and growth prospects across the Advanced Breast Cancer in Premenopausal Women market. A detailed picture of the Advanced Breast Cancer in Premenopausal Women pipeline landscape is provided, which includes the disease overview and ... Read More
-
Advanced Pancreatic Cancer - Pipeline Insight, 2024
... Cancer market. A detailed picture of the Advanced Pancreatic Cancer pipeline landscape is provided, which includes the disease overview and Advanced Pancreatic Cancer treatment guidelines. The assessment part of the report embraces in-depth Advanced Pancreatic ... Read More
-
Anaplastic lymphoma kinase inhibitors - Pipeline Insight, 2024
... pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive ... Read More
-
Anaplastic Lymphoma Kinase (ALK) Positive, Advanced Non–Small Cell Lung Cancer - Pipeline Insight, 2024
... companies and 3+ pipeline drugs in Anaplastic Lymphoma Kinase (ALK) Positive, Advanced Non–Small Cell Lung Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics ... Read More
-
2024 Global Cancer Monocolonal Antibodies Industry (2030 Outlook)
... Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include the total ... Read More
-
Transitional Cell Carcinoma - Pipeline Insight, 2024
... Carcinoma market. A detailed picture of the Transitional Cell Carcinoma pipeline landscape is provided, which includes the disease overview and Transitional Cell Carcinoma treatment guidelines. The assessment part of the report embraces in-depth Transitional Cell ... Read More
-
Non-Small-Cell Lung cancer (NSCLC) - Pipeline Insight, 2024
... It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products ... Read More
-
2024 Global Cancer Gene Therapy Market Industry (2030 Outlook)
... Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include ... Read More
-
Neoantigen-based Personalized Cancer therapeutic Vaccines - Pipeline Insight, 2024
... Vaccines pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the ... Read More
-
Cancer Pain - Pipeline Insight, 2024
... picture of the Cancer Pain pipeline landscape is provided, which includes the disease overview and Cancer Pain treatment guidelines. The assessment part of the report embraces in-depth Cancer Pain commercial assessment and clinical assessment of ... Read More
-
CAR T-Cell Therapy for Acute Lymphoblastic Leukemia - Pipeline Insight, 2024
... CAR T-Cell Therapy for Acute Lymphoblastic Leukemia pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and ... Read More
-
2024 Global Cancer/Tumor Profiling Market Industry (2030 Outlook)
... Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include the total ... Read More
-
Multiple Myeloma Market Insight, Epidemiology And Market Forecast - 2034
... in the 7MM is expected to increase, driven by the launch of emerging therapies. DelveInsight’s analyst projects that among the Total Diagnosed Prevalent Cases of Fuchs Endothelial Corneal Dystrophy (FECD) in the 7MM approximately 35% ... Read More
-
AIDS Related Kaposi's Sarcoma - Pipeline Insight, 2024
... the AIDS Related Kaposi's Sarcoma market. A detailed picture of the AIDS Related Kaposi's Sarcoma pipeline landscape is provided, which includes the disease overview and AIDS Related Kaposi's Sarcoma treatment guidelines. The assessment part of ... Read More
-
2024 Global Cancer Registry Software Market Industry (2030 Outlook)
... Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include ... Read More
-
CAR T-Cell Therapy for Non-Hodgkin’s lymphoma– - Pipeline Insight, 2024
... Therapy for Non-Hodgkin’s Lymphoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It ... Read More
-
Global Prostate Cancer Antigen 3 Test Market Insights, Forecast to 2030
... at a CAGR of 9.09% during 2024-2030. The US & Canada market for Prostate Cancer Antigen 3 Test is estimated to increase from $ 19.1 million in 2023 to reach $ 34.31 million by 2030, ... Read More
-
2024 Global Cancer Vaccine Market Industry (2030 Outlook)
... Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include the total ... Read More
-
2024 Global Cancer Biomarkers Market Industry (2030 Outlook)
... Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include the total ... Read More
-
2024 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Industry (2030 Outlook)
... (Wharry Sharpe Research) The Global Advanced Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market ... Read More
-
2024 Global Cancer Diagnostics Market Industry (2030 Outlook)
... Market Outlook reports provide market size data for a three-year historical trend (2018-2021), a three-year forecast estimate trends (2022-2024), and a five-year outlook projection (2025-2030) for 46 countries. Market and product shipments include the total ... Read More
-
Thymus Cancer - Pipeline Insight, 2024
... picture of the Thymus Cancer pipeline landscape is provided, which includes the disease overview and Thymus Cancer treatment guidelines. The assessment part of the report embraces in-depth Thymus Cancer commercial assessment and clinical assessment of ... Read More
-
Undifferentiated Pleomorphic Sarcoma (UPS) - Pipeline Insight, 2024
... the Undifferentiated Pleomorphic Sarcoma (UPS) market. A detailed picture of the Undifferentiated Pleomorphic Sarcoma (UPS) pipeline landscape is provided, which includes the disease overview and Undifferentiated Pleomorphic Sarcoma (UPS) treatment guidelines. The assessment part of ... Read More
-
Acute Myelogenous Leukemia (AML) - Pipeline Insight, 2024
... the Acute Myelogenous Leukemia (AML) market. A detailed picture of the Acute Myelogenous Leukemia (AML) pipeline landscape is provided, which includes the disease overview and Acute Myelogenous Leukemia (AML) treatment guidelines. The assessment part of ... Read More
-
Advanced Cancer Pain Management (ACPM) - Pipeline Insight, 2024
... growth prospects across the Advanced Cancer Pain Management (ACPM) market. A detailed picture of the Advanced Cancer Pain Management (ACPM) pipeline landscape is provided, which includes the disease overview and Advanced Cancer Pain Management (ACPM) ... Read More
Research Assistance
